Lymphatic Malformations Clinical Trial
Official title:
Airway Vascular Lesions
Controversy exists in the treatment of airway hemangiomas ranging from tracheotomy, various lasers, to open removal, none of which have proven to be a gold standard. Venous malformations of the airway are difficult to treat and also require laser therapy or open removal and often repeated treatments are required. Similarly airway lymphatic malformations can require multiple treatment modalities as well as multiple procedures and are infrequently eradicated when extensive. New uses for various lasers and differing treatment protocols are frequently developed. Review of the treatment modalities and efficacy of these methods is required. The goal of this research is to determine protocols for treatment of airway vascular malformation and to evaluate our results from treatment of these lesions.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01212965 -
Selenium in the Treatment of Complicated Lymphatic Malformations
|
Phase 1 | |
Completed |
NCT03427619 -
OK432 (Picibanil) in the Treatment of Lymphatic Malformations
|
Phase 2 | |
Recruiting |
NCT05948943 -
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
|
Phase 2/Phase 3 | |
Completed |
NCT02335242 -
Sildenafil for the Treatment of Lymphatic Malformations
|
Phase 2 | |
Completed |
NCT00577213 -
Diagnosis of Hemangiomas and Vascular Malformations
|
N/A | |
Completed |
NCT00010452 -
Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations
|
Phase 2/Phase 3 |